ALIMP.PA · Implanet S.A

-

Please sign in to comment on ALIMP.PA

1 Comment

Admin

4 years, 1 month ago

Implanet S.A is currently in a long term downtrend where the price is trading 14.2% below its 200 day moving average.

From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.6.

Implanet S.A's total revenue sank by 0.0% to $2M since the same quarter in the previous year.

Its net income has dropped by 0.0% to $-910K since the same quarter in the previous year.

Finally, its free cash flow grew by 2.9% to $-831K since the same quarter in the previous year.

Based on the above factors, Implanet S.A gets an overall score of 2/5.

Industry	Medical Devices
Sector	Healthcare
Exchange	PA
CurrencyCode	EUR
ISIN	FR0013470168

Beta	1.01
PE Ratio	None
Target Price	2
Market Cap	13M
Dividend Yield	None

ABOUT

Implanet S.A

Implanet S.A., a medical technology company, manufactures and sells implants and instrument for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation. It also provides ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. Implanet S.A.was founded in 2006 and is based in Martillac, France.

ALIMP.PA · Implanet S.A

-

Implanet S.A

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Implanet S.A using a moving average strategy